Cargando…
Red blood cell distribution width and the risk of being in poor glycemic control among patients with established type 2 diabetes
BACKGROUND: The red cell distribution width (RDW) has been shown to be associated with the incidence and complications of type 2 diabetes (T2D). However, the relevance of RDW with the risk of being in poor glycemic control among patients with established T2D is largely overlooked. METHODS: A total o...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818876/ https://www.ncbi.nlm.nih.gov/pubmed/29497303 http://dx.doi.org/10.2147/TCRM.S155753 |
_version_ | 1783301098969235456 |
---|---|
author | Yin, Yaqi Ye, Sisi Wang, Haibin Li, Bing Wang, Anping Yan, Wenhua Dou, Jingtao Mu, Yiming |
author_facet | Yin, Yaqi Ye, Sisi Wang, Haibin Li, Bing Wang, Anping Yan, Wenhua Dou, Jingtao Mu, Yiming |
author_sort | Yin, Yaqi |
collection | PubMed |
description | BACKGROUND: The red cell distribution width (RDW) has been shown to be associated with the incidence and complications of type 2 diabetes (T2D). However, the relevance of RDW with the risk of being in poor glycemic control among patients with established T2D is largely overlooked. METHODS: A total of 702 T2D participants from the REACTION study were enrolled in this study. Blood routine index, fasting plasma glucose, hemoglobin A1c and lipid profile data were available for all of the enrolled population. RESULTS: The univariate logistic analysis revealed a significant association between RDW and the risk of being in poor glycemic control among T2D subjects with an odds ratio (OR) and a 95% confidence interval (CI) of 0.5 and 0.3–0.8, respectively, for the fourth vs the first quartile of RDW. The association strengthened after multivariable adjustment (OR [95% CI]: 0.3 [0.2–0.7]). Interaction and stratified analyses indicated that this association was seen only among T2D subjects with lower body mass index and/or serum lipid levels. CONCLUSION: T2D patients with higher RDW had significantly lower risk of being in poor glycemic control. RDW may contribute to risk assessment for T2D individuals at risk of being in poor glycemic control. |
format | Online Article Text |
id | pubmed-5818876 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-58188762018-03-01 Red blood cell distribution width and the risk of being in poor glycemic control among patients with established type 2 diabetes Yin, Yaqi Ye, Sisi Wang, Haibin Li, Bing Wang, Anping Yan, Wenhua Dou, Jingtao Mu, Yiming Ther Clin Risk Manag Original Research BACKGROUND: The red cell distribution width (RDW) has been shown to be associated with the incidence and complications of type 2 diabetes (T2D). However, the relevance of RDW with the risk of being in poor glycemic control among patients with established T2D is largely overlooked. METHODS: A total of 702 T2D participants from the REACTION study were enrolled in this study. Blood routine index, fasting plasma glucose, hemoglobin A1c and lipid profile data were available for all of the enrolled population. RESULTS: The univariate logistic analysis revealed a significant association between RDW and the risk of being in poor glycemic control among T2D subjects with an odds ratio (OR) and a 95% confidence interval (CI) of 0.5 and 0.3–0.8, respectively, for the fourth vs the first quartile of RDW. The association strengthened after multivariable adjustment (OR [95% CI]: 0.3 [0.2–0.7]). Interaction and stratified analyses indicated that this association was seen only among T2D subjects with lower body mass index and/or serum lipid levels. CONCLUSION: T2D patients with higher RDW had significantly lower risk of being in poor glycemic control. RDW may contribute to risk assessment for T2D individuals at risk of being in poor glycemic control. Dove Medical Press 2018-02-14 /pmc/articles/PMC5818876/ /pubmed/29497303 http://dx.doi.org/10.2147/TCRM.S155753 Text en © 2018 Yin et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Yin, Yaqi Ye, Sisi Wang, Haibin Li, Bing Wang, Anping Yan, Wenhua Dou, Jingtao Mu, Yiming Red blood cell distribution width and the risk of being in poor glycemic control among patients with established type 2 diabetes |
title | Red blood cell distribution width and the risk of being in poor glycemic control among patients with established type 2 diabetes |
title_full | Red blood cell distribution width and the risk of being in poor glycemic control among patients with established type 2 diabetes |
title_fullStr | Red blood cell distribution width and the risk of being in poor glycemic control among patients with established type 2 diabetes |
title_full_unstemmed | Red blood cell distribution width and the risk of being in poor glycemic control among patients with established type 2 diabetes |
title_short | Red blood cell distribution width and the risk of being in poor glycemic control among patients with established type 2 diabetes |
title_sort | red blood cell distribution width and the risk of being in poor glycemic control among patients with established type 2 diabetes |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818876/ https://www.ncbi.nlm.nih.gov/pubmed/29497303 http://dx.doi.org/10.2147/TCRM.S155753 |
work_keys_str_mv | AT yinyaqi redbloodcelldistributionwidthandtheriskofbeinginpoorglycemiccontrolamongpatientswithestablishedtype2diabetes AT yesisi redbloodcelldistributionwidthandtheriskofbeinginpoorglycemiccontrolamongpatientswithestablishedtype2diabetes AT wanghaibin redbloodcelldistributionwidthandtheriskofbeinginpoorglycemiccontrolamongpatientswithestablishedtype2diabetes AT libing redbloodcelldistributionwidthandtheriskofbeinginpoorglycemiccontrolamongpatientswithestablishedtype2diabetes AT wanganping redbloodcelldistributionwidthandtheriskofbeinginpoorglycemiccontrolamongpatientswithestablishedtype2diabetes AT yanwenhua redbloodcelldistributionwidthandtheriskofbeinginpoorglycemiccontrolamongpatientswithestablishedtype2diabetes AT doujingtao redbloodcelldistributionwidthandtheriskofbeinginpoorglycemiccontrolamongpatientswithestablishedtype2diabetes AT muyiming redbloodcelldistributionwidthandtheriskofbeinginpoorglycemiccontrolamongpatientswithestablishedtype2diabetes |